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Summary
Background: We assessed the impact of remodeling patterns on pre- and post-infarction;
Remodeling;
Plaque;
Intravascular ultrasound
procedural intravascular ultrasound (IVUS) ﬁndings and cardiac enzyme elevation
after stenting in 310 acute myocardial infarction (AMI) patients.
Methods: The positive remodeling (PR) (PR group, n = 113) was deﬁned as remodel-
ing index (lesion/reference external elastic membrane cross-sectional area) >1.05,
intermediate remodeling (IR) as between 0.95 and 1.05, and negative remodeling
(NR) as < 0.95 (IR/NR group, n = 197). IVUS ﬁndings included ruptured plaque (a cavity
that communicated with the lumen with an overlying residual ﬁbrous cap fragment),
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multiple ruptured plaques (d
of artery containing smooth
defects), and plaque prolap
stenting). We compared pre
troponin I (cTnI) elevation af
Results: The plaque rupture (
14%, p = 0.014), and IVUS-det
mon in the PR group compar
was observed more frequent
signiﬁcantly after stenting in
+7.8± 51.1 ng/ml vs. +0.9±
PR [odds ratio (OR) = 1.92; 9
95% CI 1.16—3.45, p = 0.025)
p = 0.008), and plaque prola
pendently associated with po
Conclusions: AMI patients w
quency of plaque prolapse ac
compared with AMI patients
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ntroduction
atterns of arterial remodeling during the course
f plaque development have been shown to play
pivotal role in the progression of atherosclerosis
1—5]. In vivo assessment of lesion site remodeling
sing intravascular ultrasound (IVUS) is performed
y comparing the vessel area of the lesion to
he reference segment [6]. Arterial remodeling
s a heterogeneous process ranging from positive
emodeling (PR), which is usually responsible for
cute coronary syndromes, to negative remodeling
NR) which is usually associated with stenoses in
atients with stable angina [7,8]. Lesions are clas-
iﬁed as PR because the lesion site external elastic
embrane (EEM) cross-sectional area (CSA) is larger
han the reference segment, and lesions are classi-
ed as NR because the lesion site EEM CSA is smaller
han the reference segment.
Typical IVUS features of acute myocardial infarc-
ion (AMI) include PR, plaque rupture, thrombus,
nd either spotty or deep calcium within the min-
mum lumen site [9—16]. Several studies have
eported that rupture of a vulnerable plaque
nd subsequent thrombus formation is the most
mportant mechanism leading to an acute coro-
ary syndrome [17,18]. So far, data on the
re-procedural IVUS plaque characteristics and
ost-procedural IVUS ﬁndings according to the
emodeling pattern in patients with AMI are lack-
ng. We used IVUS to assess the relation between
emodeling pattern and pre- and post-procedural
VUS ﬁndings in AMI.
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ifferent plaque ruptures separated by a >5-mm length
lumen contours), thrombus (discrete intraluminal ﬁlling
se (tissue extrusion through the stent strut at post-
- and post-procedural IVUS ﬁndings and cardiac-speciﬁc
ter stenting according to the remodeling pattern.
60% vs. 42%, p = 0.004), multiple plaque ruptures (22% vs.
ected thrombus (42% vs. 28%, p = 0.012) were more com-
ed with the IR/NR group. Post-stenting plaque prolapse
ly (36% vs. 22%, p = 0.008), and cTnI was elevated more
the PR group compared with the IR/NR group (cTnI;
41.1 ng/ml, p = 0.008). Multivariate analysis showed that
5% CI 1.04—2.98, p = 0.028], plaque rupture (OR 1.98;
, IVUS-detected thrombus (OR 2.30; 95% CI 1.22—3.98,
pse (OR 8.40; 95% CI 4.19—16.84, p < 0.001) were inde-
st-stenting cTnI elevation.
ith PR have more plaque vulnerability and higher fre-
companied by post-procedural cardiac enzyme elevation
with IR/NR.
Cardiology. Published by Elsevier Ireland Ltd. All rights
ethods
tudy population
rom January 9, 2001 to July 31, 2007, we
dentiﬁed a total of 310 patients with a ﬁrst
MI who underwent pre-intervention IVUS within
4 h from symptom onset, were stented success-
ully, and had post-intervention IVUS imaging. We
xcluded patients with prior MI, stent throm-
osis, in-stent restenosis lesion, coronary artery
ypass graft failure, severe heart failure or car-
iogenic shock, patients studied with IVUS more
han 24 h after symptom onset, and patients in
hom adequate IVUS images could not be obtained.
ll 310 infarct lesions were treated with stent
mplantation: 187 with drug-eluting stents [138
ith sirolimus-eluting stents (Cypher stent, Cordis,
ohnson and Johnson, Miami Lakes, FL, USA) and 49
ith paclitaxel-eluting stents (Taxus stent, Boston
cientiﬁc, Boston, MA, USA)], and 123 with bare
etal stents.
The presence of ST-segment elevation MI was
etermined by >30min of continuous chest pain,
new ST-segment elevation ≥2mm on at least
wo contiguous electrocardiographic leads, and
reatine kinase-MB >3 times normal. The pres-
nce of non-ST-segment elevation MI was diagnosed
y chest pain and a positive cardiac biochem-
cal marker without new ST-segment elevation.
nfarct-related arteries were identiﬁed using a
ombination of electrocardiographic ﬁndings, left
entricular wall motion abnormalities on left
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ventricular angiogram or two-dimensional echocar-
diogram, and coronary angiogram. The protocol was
approved by the institutional review board. Hos-
pital records of patients were reviewed to obtain
information on clinical demographics.
Laboratory analysis
Venous blood samples were obtained within 24 h
after stenting. The blood samples were cen-
trifuged, and serum was removed and stored at
−70 ◦C until the assay could be performed. Cardiac-
speciﬁc troponin I (cTnI) levels were measured
by a paramagnetic particle, chemiluminescent
immunoenzymatic assay (Beckman, Coulter Inc.,
Fullerton, CA, USA). The serum levels of total
cholesterol, triglyceride, low-density lipoprotein
cholesterol, and high-density lipoprotein choles-
terol were measured by standard enzymatic
methods. High-sensitivity C-reactive protein was
analyzed turbidimetrically with sheep antibodies
against human C-reactive protein; this has been
validated against the Dade-Behring method [19].
Quantitative coronary angiography (QCA)
analysis
Coronary angiogram was analyzed with validated
QCA system (Philips H5000 or Allura DCI pro-
gram, Philips Medical Systems, Eindhoven, the
Netherlands). With the outer diameter of the
contrast-ﬁlled catheter as the calibration stan-
dard, the minimal lumen diameter and reference
diameter were measured in diastolic frames from
orthogonal projections.
IVUS imaging and analysis
All IVUS examinations were performed before and
after stenting after intracoronary administration of
300g nitroglycerin using a commercially available
IVUS system (Boston Scientiﬁc Corporation/SCIMed,
Minneapolis, MN, USA). The IVUS catheter was
advanced distal to the target lesion, and imaging
was performed retrograde to the aorto-ostial junc-
tion at an automatic pullback speed of 0.5mm/sec.
IVUS analysis was performed according to the
American College of Cardiology Clinical Expert
Consensus Document on Standards for Acqusition,
Measurement and Reporting of Intravascular Ultra-
sound Studies [6]. EEM and lumen CSAs were
measured. Plaque plus media (P&M) CSA was calcu-
lated as EEM minus lumen CSA; and plaque burden
was calculated as P&M divided by EEM CSA. Prox-
imal and distal references were the single slices
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ith the largest lumen and smallest plaque CSAs
ithin 10mm proximally and distally, but before
ny large side branch. The lesion was the site
ith the smallest lumen CSA; if there were mul-
iple image slices with the same minimum lumen
SA, then the image slice with the largest EEM
nd P&M was measured. Coronary artery remod-
ling was assessed by comparing the lesion site
o the reference EEM CSA. Remodeling index was
he lesion site EEM CSA divided by the average of
he proximal and distal reference EEM CSA. PR was
eﬁned as a remodeling index >1.05, intermediate
emodeling (IR) as a remodeling index between 0.95
nd 1.05, and NR as a remodeling index <0.95 [20].
ypoechoic plaque was less bright compared with
he reference adventitia. Hyperechoic, noncalci-
ed plaque was as bright as or brighter than the
eference adventitia without acoustic shadowing.
alcium plaque was hyperechoic with shadowing.
calciﬁed lesion contained >90◦ of circumferential
esion calcium. When there was no dominant plaque
omposition, the plaque was classiﬁed as mixed.
A ruptured plaque contained a cavity that
ommunicated with the lumen with an overlying
esidual ﬁbrous cap fragment. A fragmented and
oosely adherent plaque without a distinct cavity
nd without a ﬁbrous cap fragment was not consid-
red a plaque rupture. Rupture sites separated by a
ength of artery containing smooth lumen contours
ithout cavities were considered to represent dif-
erent plaque ruptures [21,22]. Plaque cavity was
easured and extrapolated to the ruptured capsule
rea. Thrombus was an intraluminal mass having a
ayered or lobulated appearance, evidence of blood
ow (microchannels) within themass, and speckling
r scintillation [22,23]. A lipid-pool like image was
eﬁned as a pooling of hypoechoic or echolucent
aterial covered with a hyperechoic layer.
At post-intervention, we measured the minimum
tent CSA. Percent stent expansion was calculated
s minimum stent CSA divided by mean refer-
nce lumen CSA. Plaque prolapse was deﬁned as
issue extrusion through the stent strut at post-
ntervention.
tatistical analysis
he statistical Package for Social Sciences (SPSS)
or Windows, version 15.0 (Chicago, IL, USA) was
sed for all analyses. Continuous variables were
resented as the mean value ±1SD; comparisons
ere conducted by Student’s t-test or nonpara-
etric Wilcoxon test if normality assumption was
iolated. Discrete variables were presented as per-
entages and relative frequencies; comparisons
ere conducted by chi-square statistics or Fisher’s
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Table 1 Baseline characteristics.
PR (n = 113) IR/NR (n = 197) p-value
Age (years) 62± 13 66± 11 0.043
Male gender 72 (64) 107 (54) 0.11
Clinical presentation 0.9
NSTEMI 68 (61) 117 (59)
STEMI 45 (40) 80 (41)
Diabetes mellitus 46 (41) 65 (33) .17
Hypertension 89 (79) 151 (77) 0.7
Smoking 35 (31) 70 (36) 0.4
Family history of coronary artery disease 26 (23) 26 (13) 0.026
Glycoprotein IIb/IIIa inhibitors 26 (23) 34 (17) 0.2
Use of distal protection devices 13 (12) 11 (6) 0.060
Ejection fraction (%) 43± 13 46± 12 0.099
cTnI (ng/ml) 16.6± 47.4 14.4± 40.3 0.7
White blood cells (103/mm3) 9.8± 4.1 8.8± 3.1 0.091
Hemoglobin (g/dl) 12.2± 2.2 12.3± 2.1 0.8
Platelet count (103/mm3) 243± 89 222± 85 0.12
Creatinine clearance (ml/min) 60± 36 64± 31 0.3
Total cholesterol (mg/dl) 172± 47 168± 43 0.6
Triglyceride (mg/dl) 136± 49 125± 71 0.2
LDL-cholesterol (mg/dl) 105± 42 102± 37 0.6
HDL-cholesterol (mg/dl) 42± 12 43± 14 0.3
High-sensitivity C-reactive protein (mg/dl) 2.4± 5.4 1.9± 3.4 0.5
Data are n (%), or mean± SD. PR, positive remodeling; IR/NR, intermediate remodeling/negative remodeling; NSTEMI, non-ST
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LDL, low-density lipoprotein; HDL, high-density lipoprotein.
xact test as appropriate. Multivariate analysis
as performed to identify independent predictors
f post-stenting cTnI elevation. Univariate analy-
es were ﬁrst conducted to identify potential risk
actors for post-stenting cTnI elevation. The like-
ihood ratio test was used, and the variables with
p-value of < 0.2 were included in the multivari-
te model. Finally, a stepdown logistic regression
as performed. The least signiﬁcant variable was
ropped at each step until only covariates with a
-value < 0.05 remained. A p-value < 0.05 was con-
idered statistically signiﬁcant.
esults
atient characteristics
he baseline characteristics are summarized in
able 1. The PR group was younger and had more
amily history of coronary artery disease compared
ith the IR/NR group. There were trends toward
ore frequent use of distal protection devices,
ower ejection fraction, and higher white blood cell
ounts in the PR group compared with the IR/NR
roup.
I
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stion myocardial infarction; cTnI, cardiac-speciﬁc troponin I;
ngiographic and procedural results
ngiographic ﬁndings and procedural results are
ummarized in Table 2. Although there were no
igniﬁcant differences in infarct-related arteries,
esion location, number of diseased vessels, Throm-
olysis In Myocardial Infarction (TIMI) ﬂow grade,
sed stent types, and stent diameter and length
etween the PR group and the IR/NR group, angio-
raphic lesion length was signiﬁcantly longer and
nﬂation pressure for stent implantation was sig-
iﬁcantly higher in the PR group compared with
he IR/NR group. There was a strong trend toward
ncreased PR when paclitaxel-eluting stents were
sed, compared with sirolimus-eluting or bare-
etal stents [paclitaxel-eluting stent, 19/49 (39%);
irolimus-eluting stent, 35/138 (25%); bare-metal
tent, 31/123 (25%); p = 0.15)].
VUS resultsVUS ﬁndings are summarized in Table 3. Lesion
ite EEM CSA, P&M CSA, and plaque burden were
igniﬁcantly greater in lesions with PR compared
ith lesions with IR/NR. IVUS lesion length was
igniﬁcantly longer, and calcium arc was signiﬁ-
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Table 2 Coronary angiographic ﬁndings and procedural results.
PR (n = 113) IR/NR (n = 197) p-value
Infarct-related artery 0.12
Left main 3 (3) 2 (1)
Left anterior descending artery 54 (48) 113 (57)
Left circumﬂex artery 13 (12) 29 (15)
Right coronary artery 43 (38) 53 (27)
Lesion location 0.096
Ostium 1 (1) 3 (2)
Proximal 37 (33) 84 (43)
Middle 67 (59) 88 (45)
Distal 8 (7) 22 (11)
Multivessel disease 54 (48) 100 (51) 0.4
TIMI ﬂow grade 0 23 (20) 35 (18) 0.5
Stent type 0.17
Sirolimus-eluting stent 53 (47) 85 (43)
Paclitaxel-eluting stent 12 (11) 37 (19)
Bare-metal stent 48 (43) 75 (38)
No. of deployed stents 1.25± 0.53 1.16± 0.38 0.13
Stent diameter (mm) 3.31± 0.50 3.22± 0.41 0.10
Stent length (mm) 24.9± 11.6 23.6± 10.4 0.3
Inﬂation pressure (mmHg) 14.8± 2.7 14.2± 2.8 0.039
Reference diameter (mm) 3.26± 0.89 3.32± 0.75 0.5
Pre-MLD (mm) 0.63± 0.32 0.65± 0.51 0.7
Lesion length (mm) 21± 10 18± 8 0.031
Data are n (%), or mean± SD. PR, positive remodeling; IR/NR, intermediate remodeling/negative remodeling; TIMI, thrombolysis
in myocardial infarction; MLD, minimal lumen diameter.
Table 3 Intravascular ultrasound ﬁndings.
PR (n = 113) IR/NR (n = 197) p-value
Reference
EEM CSA (mm2) 12.3± 4.5 13.2± 4.8 0.13
Lumen CSA (mm2) 8.3± 3.2 9.0± 3.0 0.11
P&M CSA (mm2) 4.0± 2.2 4.2± 2.8 0.6
Plaque burden (%) 32± 12 32± 11 1.0
Lesion site
EEM CSA (mm2) 14.6± 5.0 11.3± 3.9 <0.001
Lumen CSA (mm2) 2.6± 1.6 2.4± 1.0 0.7
P&M CSA (mm2) 12.0± 4.5 8.9± 3.9 <0.001
Plaque burden (%) 82± 36 76± 30 0.014
IVUS lesion length (mm) 26± 16 22± 12 0.026
Calcium arc (◦) 97± 106 150± 106 <0.001
Lipid-pool like image 45 (40) 51 (26) 0.011
Scattered calciﬁcation 70 (62) 81 (41) <0.001
Plaque morphology <0.001
Hypoechoic 72 (64) 80 (41)
Hyperechoic, non-calciﬁed 21 (19) 31 (16)
Hyperechoic, calciﬁed 12 (11) 66 (34)
Mixed 8 (7) 20 (10)
Remodeling index 1.20± 0.18 0.88± 0.13 <0.001
Minimum stent CSA (mm2) 7.92± 2.64 7.75± 2.56 0.079
Stent expansion (%) 95± 22 86± 29 0.034
Data are n (%), or mean± SD. PR, positive remodeling; IR/NR, intermediate remodeling/negative remodeling; EEM, external elastic
membrane; CSA, cross-sectional area; P&M, plaque plus media; IVUS, intravascular ultrasound.
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Fig. 1 The incidence of plaque rupture and multiple
plaque ruptures in lesions with positive remodeling (PR)
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Fig. 2 Plaque cavity area (A) and ruptured plaque length
(B) in lesions with positive remodeling (PR) vs. lesions
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t
and plaque prolapse (OR 8.40; 95% CI 4.19—16.84,
p < 0.001) were independently associated with
post-stenting cTnI elevation.s. lesions with intermediate remodeling (IR)/negative
emodeling (NR).
antly smaller in lesions with PR compared with
esions with IR/NR. The presence of lipid-pool
ike image, scattered calciﬁcation, and hypoe-
hoic plaque were signiﬁcantly more common in
esions with PR compared with lesions with IR/NR.
ercent stent expansion was signiﬁcantly greater
n lesions with PR compared with lesions with
R/NR.
Plaque rupture and multiple plaque ruptures
ere observed more frequently in lesions with
R compared with lesions with IR/NR (Fig. 1).
laque cavity CSA was signiﬁcantly greater and
uptured plaque length was signiﬁcantly longer in
esions with PR compared with lesions with IR/NR
Fig. 2). IVUS-detected thrombus was observed
ore frequently in lesions with PR compared with
esions with IR/NR (Fig. 3). At post-intervention,
laque prolapse was observed more frequently in
esions with PR compared with lesions with IR/NR
Fig. 4).
ost-stenting cTnI elevation
verall, cTnI was elevated after stenting in 179
atients (58% of the enrolled patients). cTnI
as more signiﬁcantly elevated after stenting
n patients with PR compared with patients
ithout IR/NR (cTnI; +7.8± 51.1 ng/ml vs.
0.9± 41.1 ng/ml, p = 0.008). Multiple logistic
egression analysis was performed to determine
ndependent predictors of post-stenting cTnI
levation. The following variables were tested (all
ith p < 0.2 in univariate analysis): male gender,
iabetes mellitus, TIMI ﬂow grade 0, stent length,
VUS plaque burden at the minimum lumen sites,
laque rupture, IVUS-detected thrombus, PR,
laque prolapse, and percent stent expansion.
R [odds ratio (OR) 1.92; 95% conﬁdence interval
F
(
e
(ith intermediate remodeling (IR)/negative remodeling
NR).
CI) 1.04—2.98, p = 0.028], plaque rupture (OR
.98; 95% CI 1.16—3.45, p = 0.025), IVUS-detected
hrombus (OR 2.30; 95% CI 1.22—3.98, p = 0.008),ig. 3 The incidence of intravascular ultrasound
IVUS)-detected thrombus in lesions with positive remod-
ling (PR) vs. lesions with intermediate remodeling
IR)/negative remodeling (NR).
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Fig. 4 The incidence of post-stenting plaque prolapse
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and thrombus should be avoided to prevent post-in lesions with positive remodeling (PR) vs. lesions with
intermediate remodeling (IR)/negative remodeling (NR).
Discussion
The present IVUS study demonstrated that AMI
patients with PR had: 1) greater lesion site
plaque burden, longer lesion length, and less
severe calciﬁcation; 2) more lipid-pool like image,
more scattered calciﬁcation, and more hypoechoic
plaque; 3) greater percent stent expansion; 4)
more plaque rupture and multiple plaque rup-
tures and more IVUS-detected thrombus; 5) more
post-stenting plaque prolapsed; and 6) more sig-
niﬁcant cTnI elevation after stenting. Therefore,
AMI patients with PR have more plaque vulner-
ability and higher frequency of plaque prolapse
accompanied by more post-procedural myonecrosis
compared with AMI patients with IR/NR.
Coronary arteries respond to plaque growth by
either outward expansion of the vessel wall (PR)
[1,2] or vessel shrinkage (NR) [3—5]. Several stud-
ies have suggested that lesions with PR may be
both beneﬁcial (avoiding luminal stenosis) and
harmful (promoting plaque vulnerability) [8,24,25].
In contrast, lesions with NR may be associated
with signiﬁcant stenoses [5,26], but may appear
more stable. Lesions with PR are also associated
with higher long-term target lesion revascular-
ization after nonstent interventional procedures
[27], restenosis after bare-metal stent implanta-
tion [28—31], and drug-eluting stent implantation
[32].
Autopsy studies have suggested that AMI results
from spontaneous plaque rupture or erosion
and subsequent thrombosis [33,34]. Several IVUS
studies have reported varying percentage of
culprit-lesion plaque rupture in patients with acute
coronary syndrome [35—37]. Plaque ruptures tend
to occur at a point where the ﬁbrous cap is thinnest
and most heavily inﬁltrated by macrophages indi-
s
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ating ongoing inﬂammation at the site of plaque
isruption [38]. Pathological studies have shown
hat coronary artery plaques with PR have a higher
ipid content and macrophage count which are
ecognized histological markers for plaque vul-
erability [39—41]. In the present study, lesions
ith PR have more plaque rupture, more multi-
le plaque ruptures, more IVUS-detected thrombus,
ore hypoechoic plaque, more lipid-pool like
mages, and more spotty calciﬁcation compared
ith lesions with IR/NR. The results of the present
tudy are consistent with previous pathological
nd IVUS studies in which PR may make the
laque more vulnerable to rupture and cause
MI.
Plaque prolapse is an intraluminal tissue extru-
ion through stent struts and this can be easily and
requently detected by IVUS. It has been known
hat several pre-intervention IVUS features such
s hypoechoic plaque rather than ﬁbrous or calci-
ed plaque, smaller minimal lumen diameter, and a
arger plaque burden were associated with plaque
rolapse, and the risk of plaque prolapse was higher
uring aggressive stenting procedure [35,36]. Our
revious study showed that the incidence of plaque
rolapse after stenting for infarct-related artery
as 27% and pre-intervention IVUS lesion charac-
eristics — plaque rupture and PR — and longer
tent length predict plaque prolapse [42]. In the
resent study, plaque prolapse was observed more
requently in lesions with PR compared with lesions
ith IR/NR. Vulnerable plaques like PR and plaque
upture may provide the conditions for tissue extru-
ion through the stent struts.
Previous studies demonstrated that cardiac
nzyme elevation after percutaneous coronary
ntervention is associated with higher mortality
43—47]. Cardiac enzyme elevation after coronary
rtery intervention is related to the large plaque
urden and unstable plaque morphometry [48—50].
n addition to these pre-intervention IVUS ﬁndings,
ore aggressive stenting procedures appeared to
e associated with greater levels of cardiac enzyme
levation [43,50—52]. In the present study, pre-
ntervention IVUS ﬁndings — PR, plaque rupture,
VUS-detected thrombus — and post-intervention
laque prolapse were independently associated
ith cTnI elevation after stent implantation. The
esults of the present study suggest that aggres-
ive stenting with high pressure inﬂation for lesions
ith vulnerable plaque like PR, plaque rupture,tenting myonecrosis in patients with AMI because
laque prolapse is associated with aggressive stent-
ng procedures and post-stenting cardiac enzyme
levation [35,42].
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tudy limitations
irst, the present study is retrospective single-
enter study, so, is subject to limitations inherent
n this type of clinical investigation. Second, IVUS
maging was performed at the discretion of the indi-
idual operators leading to potential selection bias.
hird, it may be difﬁcult to differentiate between
n organized thrombus and plaque prolapse. IVUS
ata were analyzed by 2 independent observers
H.Y.J and C.Y.H). The presence of plaque pro-
apse was conﬁrmed when 2 independent observers
greed. However, if so, it is possible that some
ases identiﬁed as having plaque prolapse actually
ad thrombus prolapse. Fourth, volumetric IVUS
nalysis was not performed in the present study.
ifth, we excluded the patients with serious con-
itions such as severe heart failure, cardiogenic
hock, and coronary artery bypass graft failure.
hus, the present study might not represent the
hole spectrum of AMI patients. Sixth, long-term
linical follow-up was not available.
onclusions
MI patients with PR have more plaque vulnera-
ility (more plaque rupture, more multiple plaque
uptures, and more IVUS-detected thrombus) and
igher frequency of post-stenting plaque prolapse
ccompanied by more post-procedural cardiac
nzyme elevation compared with AMI patients with
R/NR.
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